Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
Viridian Therapeutics has scored an FDA
956 words~4 min read
Related reading
Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
Viridian Therapeutics has spent years moving its thyroid eye disease (TED) hopeful, veligrotug, through clinical trials a |…
Viridian may have edge over Amgen in eye drug showdown, analysts argue
The FDA, through a new approval, gave Viridian's drug a label that some on Wall Street believe makes it well-positioned to…
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For…
FDA approves Viridian Therapeutics' Lumvoa for thyroid eye disease. Immediate commercial launch scheduled with full patient…
Europe's CHMP reverses endorsement of Amgen's Tavneos as FDA hearing looms
As Amgen prepares to defend Tavneos’ market approval in the U.S., the company has received a bad omen overseas, with regulators…
Viridian Therapeutics Highlights Recent Business Progress and Reports Second…
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
FDA hearing on Amgen's Tavneos will include findings from an independent review
An independent research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing later this month with the…
